Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 4841-22-9 | MDL No. : | MFCD00063317 |
Formula : | C9H9ClO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | OSGZHKYFZSNKRI-UHFFFAOYSA-N |
M.W : | 200.62 | Pubchem ID : | 96277 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 48.84 |
TPSA : | 35.53 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.08 cm/s |
Log Po/w (iLOGP) : | 2.39 |
Log Po/w (XLOGP3) : | 2.04 |
Log Po/w (WLOGP) : | 1.89 |
Log Po/w (MLOGP) : | 1.94 |
Log Po/w (SILICOS-IT) : | 2.22 |
Consensus Log Po/w : | 2.1 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.45 |
Solubility : | 0.717 mg/ml ; 0.00358 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.41 |
Solubility : | 0.773 mg/ml ; 0.00385 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.24 |
Solubility : | 0.115 mg/ml ; 0.000575 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.78 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96.5% | Stage #1: With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.0333333 h; Stage #2: at 80℃; for 4 h; |
To a solution of 4-chlorophenol (15 g, 1 16.67 mmol, 1 equiv) in DMF (100 ml_) at room temperature was added anhydrous potassium carbonate (24.15 g, 175.01 mmol, 1 .5 equiv) portionwise. After stirring for 2 minutes, methyl-2-bromoacetate (13.3 ml_, 140.01 mmol, 1 .2 equiv) was added. The reaction mixture was heated at 80 °C for 4 h. After consumption of the starting material (TLC, 5 percent EtOAc in hexane), the reaction mixture was cooled to room temperature, diluted with water (100 ml_) and extracted with EtOAc (2 x 100 ml_). The combined organic layer was washed with brine solution (50 ml_), dried over anhydrous sodium sulphate, filtered and concentrated en vacuo to give the crude product. The crude product was purified by flash column chromatography (Combiflash) using a silica gel column and the product was eluted at 15percent ethyl acetate in hexane. Fractions containing product were concentrated to give methyl 2-(4- chlorophenoxy)acetate (22.5 g, 96.5percent yield) as pale yellow liquid. 1H NMR (400 MHz, CDC ): δ ppm 3.67 (s, 3 H), 4.78 (s, 2 H), 6.91 - 6.95 (m, 2 H), 7.28 - 7.32 (m, 2 H). |
96.5% | Stage #1: With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.0333333 h; Stage #2: at 80℃; for 4 h; |
To a solution of 4-chlorophenol (15 g, 1 16.67 mmol, 1 equiv) in DMF (100 mL) at room temperature was added anhydrous potassium carbonate (24.15 g, 175.01 mmol, 1 .5 equiv ) portionwise. After stirring for 2 minutes, methyl-2-bromoacetate (13.3 mL, 140.01 mmol, 1 .2 equiv) was added. The reaction mixture was heated at 80 °C for 4 h. After consumption of the starting material (TLC, 5 percent EtOAc in hexane), the reaction mixture was cooled to room temperature, diluted with water (100 mL) and extracted with EtOAc (2 x 100 mL). The combined organic layer was washed with brine solution (50 mL), dried over anhydrous sodium sulphate, filtered and concentrated en vacuo to give the crude product. The crude product was purified by flash column chromatography (Combiflash) using a silica gel column and the product was eluted at 15percent ethyl acetate in hexane. Fractions containing product were concentrated to give methyl 2-(4-chlorophenoxy)acetate (22.5 g, 96.5percent yield) as pale yellow liquid. NMR (400 MHz, CDCI3): δ ppm 3.67 (s, 3 H), 4.78 (s, 2 H), 6.91 - 6.95 (m, 2 H), 7.28 - 7.32 (m, 2 H). |
90% | With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 24 h; | General procedure: To a stirred solution of phenol (1 mmol) in DMF (3 mL) were added methyl bromoacetate (0.1 mL, 1 mmol) and K2CO3 (207 mg, 1.5 mmol), and the resulting mixture was heated at 80 °C for 24 h. After cooling, the reaction mixture was diluted with EtOAc, and filtered by celite pad. The filtrate was evaporated, and the residue was chromatographed on silica gel (15 g, hexane : acetone = 50 : 1 ~ 40 : 1) to give corresponding ether. |
[ 588-22-7 ]
2-(3,4-Dichlorophenoxy)acetic acid
Similarity: 0.92
[ 7417-89-2 ]
2-(4-Chloro-2-hydroxyphenoxy)acetic acid
Similarity: 0.88
[ 575-90-6 ]
2-(2,6-Dichlorophenoxy)acetic acid
Similarity: 0.81
[ 1165-91-9 ]
Bis(2,4,6-trichlorophenyl) oxalate
Similarity: 0.79
[ 3547-07-7 ]
4-(4-Chlorophenoxy)butanoic acid
Similarity: 0.77
[ 588-22-7 ]
2-(3,4-Dichlorophenoxy)acetic acid
Similarity: 0.92
[ 7417-89-2 ]
2-(4-Chloro-2-hydroxyphenoxy)acetic acid
Similarity: 0.88
[ 575-90-6 ]
2-(2,6-Dichlorophenoxy)acetic acid
Similarity: 0.81
[ 1165-91-9 ]
Bis(2,4,6-trichlorophenyl) oxalate
Similarity: 0.79
[ 3547-07-7 ]
4-(4-Chlorophenoxy)butanoic acid
Similarity: 0.77
[ 588-22-7 ]
2-(3,4-Dichlorophenoxy)acetic acid
Similarity: 0.92
[ 7417-89-2 ]
2-(4-Chloro-2-hydroxyphenoxy)acetic acid
Similarity: 0.88
[ 575-90-6 ]
2-(2,6-Dichlorophenoxy)acetic acid
Similarity: 0.81
[ 3547-07-7 ]
4-(4-Chlorophenoxy)butanoic acid
Similarity: 0.77
[ 1165-91-9 ]
Bis(2,4,6-trichlorophenyl) oxalate
Similarity: 0.79
[ 2044706-76-3 ]
Methyl 2-(3,5-dichlorophenoxy)-4-methylpentanoate
Similarity: 0.73
[ 13078-21-2 ]
Ethyl 2-(2-methoxyphenoxy)acetate
Similarity: 0.73
[ 99186-63-7 ]
Ethyl 2-(2-hydroxyphenoxy)acetate
Similarity: 0.73